215 related articles for article (PubMed ID: 30507008)
1. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
[TBL] [Abstract][Full Text] [Related]
2. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.
Esmailzadeh S; Mansoori B; Mohammadi A; Shanehbandi D; Baradaran B
J Gastrointest Cancer; 2017 Jun; 48(2):156-163. PubMed ID: 27629422
[TBL] [Abstract][Full Text] [Related]
3. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
4. Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy.
Abedi Gaballu F; Cho WC; Dehghan G; Zarebkohan A; Baradaran B; Mansoori B; Abbaspour-Ravasjani S; Mohammadi A; Sheibani N; Aghanejad A; Ezzati Nazhad Dolatabadi J
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356120
[TBL] [Abstract][Full Text] [Related]
5. HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Cycle; 2016 Oct; 15(19):2585-2592. PubMed ID: 27245202
[TBL] [Abstract][Full Text] [Related]
6. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
7. [Selection and anti-cancer effects of siRNAs targeting HMGA2 gene].
Wang QZ; Gong YH; Lü YH; Fei LN; Liu HJ; Diao Y; Xu RA
Yao Xue Xue Bao; 2011 Dec; 46(12):1444-50. PubMed ID: 22375416
[TBL] [Abstract][Full Text] [Related]
8. Effects of HMGA2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines.
Naghizadeh S; Mansoori B; Mohammadi A; Kafil HS; Mousavi Z; Sakhinia E; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):5024-5032. PubMed ID: 30317663
[TBL] [Abstract][Full Text] [Related]
9. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
Metwally AA; Blagbrough IS; Mantell JM
Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
[TBL] [Abstract][Full Text] [Related]
10. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
11. Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells.
Venkatesan N; Krishnakumar S; Deepa PR; Deepa M; Khetan V; Reddy MA
Mol Vis; 2012; 18():2420-37. PubMed ID: 23077401
[TBL] [Abstract][Full Text] [Related]
12. Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line.
Siahmansouri H; Somi MH; Babaloo Z; Baradaran B; Jadidi-Niaragh F; Atyabi F; Mohammadi H; Ahmadi M; Yousefi M
J Pharm Pharmacol; 2016 Sep; 68(9):1119-30. PubMed ID: 27350211
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
[TBL] [Abstract][Full Text] [Related]
14. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.
Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B
Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827
[TBL] [Abstract][Full Text] [Related]
15. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
17. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
18. In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer.
Bochicchio S; Dapas B; Russo I; Ciacci C; Piazza O; De Smedt S; Pottie E; Barba AA; Grassi G
Int J Pharm; 2017 Jun; 525(2):377-387. PubMed ID: 28189855
[TBL] [Abstract][Full Text] [Related]
19. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
20. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
